Trials / Completed
CompletedNCT01978860
A Prospective, First in Man Study to Evaluate the Safety and Performance of the NovaCross™ Micro-catheter
A Prospective, First in Man Study to Evaluate the Safety and Performance of the NovaCross™ Micro-catheter in (CTO) Coronary Lesions
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 2 (actual)
- Sponsor
- Chanan Schneider · Industry
- Sex
- All
- Age
- 25 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
This is a prospective, non-randomized, first-in-man investigational study, to assess the safety and technical feasibility, deployment and withdrawal characteristics of the NovaCross™ micro-catheter during an interventional coronary angioplasty procedure and evaluating the CTO penetration rate. Each study subject/patient will have a total of one (1) procedure performed for this study.
Detailed description
To be filled later
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | NovaCross, CTO | evaluate the safety and performance of the NovaCross™ micro-catheter in respect to providing additional guidewire support that is expected to allow easier crossing of Chronic Total Occlusion (CTO) lesions in coronary arteries. |
Timeline
- Start date
- 2013-11-01
- Primary completion
- 2014-11-01
- Completion
- 2014-12-01
- First posted
- 2013-11-08
- Last updated
- 2015-10-07
Locations
1 site across 1 country: Israel
Source: ClinicalTrials.gov record NCT01978860. Inclusion in this directory is not an endorsement.